da Costa Anaelle, Prehaud Christophe, Bakoa Florian, Afonso Philippe, Ceccaldi Pierre-Emmanuel, Lafaye Pierre, Lafon Monique
Institut Pasteur, CNRS UMR 3569, Unité de Neuroimmunologie Virale.
Institut Pasteur, Unité d'Epidémiologie et de Pathophysiologie des Virus Oncogènes, Université Sorbonne Paris Cité/Paris Diderot.
J Vis Exp. 2019 Apr 9(146). doi: 10.3791/59220.
The early screening of nervous system medicines on a pertinent and reliable in cellulo BBB model for their penetration and their interaction with the barrier and the brain parenchyma is still an unmet need. To fill this gap, we designed a 2D in cellulo model, the BBB-Minibrain, by combining a polyester porous membrane culture insert human BBB model with a Minibrain formed by a tri-culture of human brain cells (neurons, astrocytes and microglial cells). The BBB-Minibrain allowed us to test the transport of a neuroprotective drug candidate (e.g., Neurovita), through the BBB, to determine the specific targeting of this molecule to neurons and to show that the neuroprotective property of the drug was preserved after the drug had crossed the BBB. We have also demonstrated that BBB-Minibrain constitutes an interesting model to detect the passage of virus particles across the endothelial cells barrier and to monitor the infection of the Minibrain by neuroinvasive virus particles. The BBB-Minibrain is a reliable system, easy to handle for researcher trained in cell culture technology and predictive of the brain cells phenotypes after treatment or insult. The interest of such in cellulo testing would be twofold: introducing derisking steps early in the drug development on the one hand and reducing the use of animal testing on the other hand.
在一个相关且可靠的细胞内血脑屏障(BBB)模型上对神经系统药物进行早期筛选,以评估其穿透能力以及与屏障和脑实质的相互作用,这一需求仍未得到满足。为填补这一空白,我们设计了一种二维细胞内模型——BBB - 微型脑,它将聚酯多孔膜培养插入式人类血脑屏障模型与由人类脑细胞(神经元、星形胶质细胞和小胶质细胞)三重培养形成的微型脑相结合。BBB - 微型脑使我们能够测试一种神经保护候选药物(如Neurovita)通过血脑屏障的转运情况,确定该分子对神经元的特异性靶向作用,并表明药物穿过血脑屏障后其神经保护特性得以保留。我们还证明,BBB - 微型脑是一个有趣的模型,可用于检测病毒颗粒穿过内皮细胞屏障的情况,并监测神经侵袭性病毒颗粒对微型脑的感染。BBB - 微型脑是一个可靠的系统,对于接受过细胞培养技术培训的研究人员来说易于操作,并且能够预测治疗或损伤后脑细胞的表型。这种细胞内测试的意义有两方面:一方面在药物开发早期引入风险降低步骤,另一方面减少动物试验的使用。